Helianthus Lifesciences Private Limited logo

Helianthus Lifesciences Private Limited

Pharmaceutical company manufacturing certified anti-diabetic, anti-hypertensive, and statin products.
2021 | Kanpur Nagar, Uttar Pradesh (India) | Active

Last Updated:

November 03, 2024
HomeCompanyHelianthus Lifesciences Private Limited

Who are the key members and board of directors at Helianthus Lifesciences?

Executive Team (1)

NameDesignationAppointment DateStatus
Nripendra Pathak InManaging Director16-Apr-2021Current

Board Members(1)

NameDesignationAppointment DateStatus
Shashi Pathak In Director 02-May-2022Current

Financial Performance of Helianthus Lifesciences.

Helianthus Lifesciences Private Limited, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.

Revenue Growth Graph
Profit Loss Graph
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metric
(FY 2023)YOY Growth
(FY 2022)(FY 2021)(FY 2020)(FY 2019)
Total Revenue
Revenue from Operations
Total Assets
Profit or Loss
Net Worth
EBITDA

Charges (Loans)

Open Charges

₹1.50 M

LenderAmountStatus

State Bank Of India

Creation Date: 20 Apr 2022
₹1.50 MOpen

How Many Employees Work at Helianthus Lifesciences?

Helianthus Lifesciences has a workforce of 0 employees as of Apr 05, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Graph

Deals i

Rating

Alerts

Latest Updates, News, and FAQs on Helianthus Lifesciences

Recent activity within the organization

  • Annual General Meeting

    Helianthus Lifesciences Private Limited last Annual general meeting of members was held on 30 Sep 2023 as per latest MCA records.

    30 Sep 2023

  • Balance Sheet

    Helianthus Lifesciences Private Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Kanpur.

    31 Mar 2023

  • Director Appointment

    Shashi Kiran Pathak was appointed as a Director was appointed as a Director on 02 May 2022 & has been associated with this company since 2 years 8 months .

    02 May 2022

  • Charges

    A charge with State Bank Of India amounted to Rs. 1.50 M with Charge ID 100561869 was registered on 20 Apr 2022.

    20 Apr 2022

  • Director Appointment

    Nripendra Kumar Pathak was appointed as a Managing Director was appointed as a Managing Director on 16 Apr 2021 & has been associated with this company since 3 years 9 months .

    16 Apr 2021

  • Company Incorporation

    Helianthus Lifesciences Private Limited was registered on 16 Apr 2021 with Roc Kanpur & aged 3 years 9 months as per MCA records.

    16 Apr 2021

Frequently asked questions

  • Helianthus Lifesciences Private Limited was incorporated on 16 Apr 2021.

  • The authorized share capital of Helianthus Lifesciences Private Limited is ₹ 1.00 M and paid-up capital is ₹ 1.00 M.

  • Currently 2 directors are associated with Helianthus Lifesciences Private Limited.

    • Nripendra Kumar Pathak
    • Shashi Kiran Pathak
  • As per Ministry of Corporate Affairs (Mca), the registered address of Helianthus Lifesciences Private Limited is H.No.1167/14 Bhure Purva, Awas Vikas Hanspuram Naubasta India, Kanpur, Uttar Pradesh, 208021.

  • The corporate identification number (CIN) of Helianthus Lifesciences Private Limited is U24239UP2021PTC145259 and the company number is 145259 as per Ministry of Corporate Affairs (MCA).

  • The Official website of Helianthus Lifesciences Private Limited is https://www.helianthuslifesciences.com

  • As per the financial statements for fiscal Year 2022, The total open charges for Helianthus Lifesciences Private Limited amount to ₹ 1.50 M.

  • The most recent Balance Sheet for Helianthus Lifesciences Private Limited was filed with the ROC on 31 Mar 2023.

People also Viewed

Similar Companies Based on Drug Formulation & Development